Research & Development

Extraction, Purification & Synthesis

Cultivation & Extraction

We will use unique cGMP mycological cultivation methods with unique psilocybe strains of mushrooms to produce Psilocybin & Psilocin

Future phase: Clinical Trial CB-002

Goal: To develop a hybrid non-hallucinogenic psychedelic molecule that binds selectively to 5-HT1A receptor over 5-HT2A receptor

Future phase: Clinical Trial CB-003

Future Phase – Development of CB003: a stacked multiple-API formula “Ayahuasca pill” investigational medicinal product for clinical trials